Cibc Bancorp Usa Inc. Vertex Pharmaceuticals Inc Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 51,700 shares of VRTX stock, worth $22.2 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
51,700Holding current value
$22.2 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding VRTX
# of Institutions
1,787Shares Held
233MCall Options Held
1.96MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA25.9MShares$11.1 Billion1.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.2MShares$10.4 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.15 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.6MShares$7.1 Billion1.27% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.05 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $110B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...